Skip to main content
Top
Published in: BMC Geriatrics 1/2022

Open Access 01-12-2022 | Mood Disorders | Research

Prevalence and associated factors of cognitive frailty in older patients with chronic kidney disease: a cross-sectional study

Authors: Jing Chang, Wenwen Hou, Yanchun Li, Shujuan Li, Kai Zhao, Yanfei Wang, Yuanping Hou, Qianmei Sun

Published in: BMC Geriatrics | Issue 1/2022

Login to get access

Abstract

Background

Chronic kidney disease (CKD) is prevalent in older adults. In the aging CKD population, cognitive frailty is more common, but its prevalence and associated risk factors need to be further investigated.

Methods

This is a cross-sectional study that enrolled patients aged ≥ 60 years with a diagnosis of CKD from January 2018 to February 2021. Patients were assessed for frailty and cognition with the FRAIL and the Mini-Mental State Examination (MMSE) scales and were divided into the cognitive frailty and non-cognitive frailty groups. Risk factors for cognitive frailty were identified by univariate and multivariate logistic regression analyses. A prediction model for cognitive frailty was built and a nomogram was plotted. The performance of the nomogram was evaluated by using a concordance index (C-index) and calibration plots.

Results

A total of 1015 older patients with CKD were enrolled, among whom 607 (59.8%) were males and 408 (40.2%) were females, with an age ranging from 60 to 98 years, and an cognitive frailty prevalence of 15.2%. The prevalence of cognitive frailty varied among the CKD stages 1–5, with rates of 4.7%, 7.5%, 13.8%, 18.5%, and 21.4%, respectively. Multivariate logistic regression analysis showed that age (OR = 1.11, 95%CI 1.08–1.14, p < 0.001), depression (OR = 2.52, 95%CI 1.54–4.11, p < 0.001), low social support (OR = 2.08, 95%CI 1.28–3.39, p = 0.003), Charlson comorbidity index (CCI) (OR = 1.92, 95%CI 1.70–2.18, p < 0.001), eGFR (OR = 0.98, 95%CI 0.96–0.99, p < 0.001) and albuminuria (OR = 5.93, 95%CI 3.28–10.74, p < 0.001) were independent risk factors affecting the association with cognitive frailty in older patients with CKD. A nomogram for assessing cognitive frailty was established and well-calibrated with a C-index of 0.91 (95%CI 0.89–0.94).

Conclusions

The prevalence of cognitive frailty was higher in older patients having CKD. Advanced age, comorbidity, depression, low social support, eGFR and albuminuria were independent risk factors for CKD accompanied with cognitive frailty.
Literature
2.
go back to reference Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394(10206):1365–75.CrossRef Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394(10206):1365–75.CrossRef
3.
go back to reference Cunha AIL, Veronese N, de Melo BS, Ricci NA. Frailty as a predictor of adverse outcomes in hospitalized older adults: a systematic review and meta-analysis. Ageing Res Rev. 2019;56:100960.CrossRef Cunha AIL, Veronese N, de Melo BS, Ricci NA. Frailty as a predictor of adverse outcomes in hospitalized older adults: a systematic review and meta-analysis. Ageing Res Rev. 2019;56:100960.CrossRef
4.
go back to reference Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet. 2019;394(10206):1376–86.CrossRef Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet. 2019;394(10206):1376–86.CrossRef
5.
go back to reference Robertson DA, Savva GM, Kenny RA. Frailty and cognitive impairment–a review of the evidence and causal mechanisms. Ageing Res Rev. 2013;12:840–51.CrossRef Robertson DA, Savva GM, Kenny RA. Frailty and cognitive impairment–a review of the evidence and causal mechanisms. Ageing Res Rev. 2013;12:840–51.CrossRef
6.
go back to reference Avila-Funes JA, Amieva H, Barberger-Gateau P, Le Goff M, Raoux N, Ritchie K, et al. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc. 2009;57:453–61.CrossRef Avila-Funes JA, Amieva H, Barberger-Gateau P, Le Goff M, Raoux N, Ritchie K, et al. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc. 2009;57:453–61.CrossRef
7.
go back to reference Kelaiditi E, Cesari M, Canevelli M, van Kan GA, Ousset PJ, Gillette-Guyonnet S, et al. Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging. 2013;17:726–34.CrossRef Kelaiditi E, Cesari M, Canevelli M, van Kan GA, Ousset PJ, Gillette-Guyonnet S, et al. Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging. 2013;17:726–34.CrossRef
8.
go back to reference Ruan Q, Yu Z, Chen M, Bao Z, Li J, He W. Cognitive frailty, a novel target for the prevention of elderly dependency. Ageing Res Rev. 2015;20:1–10.CrossRef Ruan Q, Yu Z, Chen M, Bao Z, Li J, He W. Cognitive frailty, a novel target for the prevention of elderly dependency. Ageing Res Rev. 2015;20:1–10.CrossRef
9.
go back to reference Bu Z, Huang A, Xue M, Li Q, Bai Y, Xu G. Cognitive frailty as a predictor of adverse outcomes among older adults: a systematic review and meta-analysis. Brain Behav. 2021;11:e01926.CrossRef Bu Z, Huang A, Xue M, Li Q, Bai Y, Xu G. Cognitive frailty as a predictor of adverse outcomes among older adults: a systematic review and meta-analysis. Brain Behav. 2021;11:e01926.CrossRef
10.
go back to reference Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815–22.CrossRef Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815–22.CrossRef
11.
go back to reference Shen Z, Ruan Q, Yu Z, Sun Z. Chronic kidney disease-related physical frailty and cognitive impairment: a systemic review. Geriatr Gerontol Int. 2017;17(4):529–44.CrossRef Shen Z, Ruan Q, Yu Z, Sun Z. Chronic kidney disease-related physical frailty and cognitive impairment: a systemic review. Geriatr Gerontol Int. 2017;17(4):529–44.CrossRef
12.
go back to reference Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825–30.CrossRef Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825–30.CrossRef
13.
go back to reference Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging. 2012;16:601–8.CrossRef Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging. 2012;16:601–8.CrossRef
14.
go back to reference Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRef Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRef
15.
go back to reference Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.CrossRef Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.CrossRef
16.
go back to reference Cruice M, Worrall L, Hickson L. Reporting on psychological well-being of older adults with chronic aphasia in the context of unaffected peers. Disabil Rehabil. 2011;33:219–28.CrossRef Cruice M, Worrall L, Hickson L. Reporting on psychological well-being of older adults with chronic aphasia in the context of unaffected peers. Disabil Rehabil. 2011;33:219–28.CrossRef
17.
go back to reference Xiao SY. Theory and application of social support scale. J Clin Psychol Med. 1994;2:98–100. Xiao SY. Theory and application of social support scale. J Clin Psychol Med. 1994;2:98–100.
18.
go back to reference Bannay A, Chaignot C, Blotière PO, Basson M, Weill A, Ricordeau P, et al. The best use of the charlson comorbidity index with electronic health care database to predict mortality. Med Care. 2016;54:188–94.CrossRef Bannay A, Chaignot C, Blotière PO, Basson M, Weill A, Ricordeau P, et al. The best use of the charlson comorbidity index with electronic health care database to predict mortality. Med Care. 2016;54:188–94.CrossRef
19.
go back to reference Asam M, Indranil D. Chronic Kidney disease and cognitive impairment. J Stroke Cerebrovasc Dis. 2021;30(9):105529.CrossRef Asam M, Indranil D. Chronic Kidney disease and cognitive impairment. J Stroke Cerebrovasc Dis. 2021;30(9):105529.CrossRef
20.
go back to reference Coppolino G, Bolignano D, Gareri P, Ruberto C, Andreucci M, Ruotolo G, et al. Kidney function and cognitive decline in frail elderly: two faces of the same coin? Int Urol Nephrol. 2018;50:1505–10.CrossRef Coppolino G, Bolignano D, Gareri P, Ruberto C, Andreucci M, Ruotolo G, et al. Kidney function and cognitive decline in frail elderly: two faces of the same coin? Int Urol Nephrol. 2018;50:1505–10.CrossRef
21.
go back to reference Fabrício DM, Chagas MHN, Diniz BS. Frailty and cognitive decline. Transl Res. 2020;221:58–64.CrossRef Fabrício DM, Chagas MHN, Diniz BS. Frailty and cognitive decline. Transl Res. 2020;221:58–64.CrossRef
22.
go back to reference Sugimoto T, Arai H, Sakurai T. An update on cognitive frailty: Its definition, impact, associated factors and underlying mechanisms, and interventions. Geriatr Gerontol Int. 2022;22(2):99–109.CrossRef Sugimoto T, Arai H, Sakurai T. An update on cognitive frailty: Its definition, impact, associated factors and underlying mechanisms, and interventions. Geriatr Gerontol Int. 2022;22(2):99–109.CrossRef
23.
go back to reference Drew DA, Weiner DE, Sarnak MJ. Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis. 2019;74(6):782–90.CrossRef Drew DA, Weiner DE, Sarnak MJ. Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis. 2019;74(6):782–90.CrossRef
24.
go back to reference Sacre JW, Magliano DJ, Zimmet PZ, Polkinghorne KR, Chadban SJ, Anstey KJ, et al. Associations of chronic kidney disease markers with cognitive function: a 12-year follow-up study. J Alzheimers Dis. 2019;70(s1):S19–30.CrossRef Sacre JW, Magliano DJ, Zimmet PZ, Polkinghorne KR, Chadban SJ, Anstey KJ, et al. Associations of chronic kidney disease markers with cognitive function: a 12-year follow-up study. J Alzheimers Dis. 2019;70(s1):S19–30.CrossRef
25.
go back to reference Walker SR, Wagner M, Tangri N. Chronic kidney disease, frailty, and unsuccessful aging: a review. J Ren Nutr. 2014;24:364–70.CrossRef Walker SR, Wagner M, Tangri N. Chronic kidney disease, frailty, and unsuccessful aging: a review. J Ren Nutr. 2014;24:364–70.CrossRef
26.
go back to reference Rivan NFM, Shahar S, Rajab NF, Singh DKA, Che Din N, Mahadzir H, et al. Incidence and predictors of cognitive frailty among older adults: a community-based longitudinal study. Int J Environ Res Public Health. 2020;17:1547.CrossRef Rivan NFM, Shahar S, Rajab NF, Singh DKA, Che Din N, Mahadzir H, et al. Incidence and predictors of cognitive frailty among older adults: a community-based longitudinal study. Int J Environ Res Public Health. 2020;17:1547.CrossRef
27.
go back to reference Jung S, Lee YK, Choi SR, Hwang SH, Noh JW. Relationship between cognitive impairment and depression in dialysis patients. Yonsei Med J. 2013;54:1447–53.CrossRef Jung S, Lee YK, Choi SR, Hwang SH, Noh JW. Relationship between cognitive impairment and depression in dialysis patients. Yonsei Med J. 2013;54:1447–53.CrossRef
28.
go back to reference Duppen D, Van der Elst MCJ, Dury S, Lambotte D, De Donder L. The social environment’s relationship with frailty: evidence from existing studies. J Appl Gerontol. 2019;38:3–26.CrossRef Duppen D, Van der Elst MCJ, Dury S, Lambotte D, De Donder L. The social environment’s relationship with frailty: evidence from existing studies. J Appl Gerontol. 2019;38:3–26.CrossRef
Metadata
Title
Prevalence and associated factors of cognitive frailty in older patients with chronic kidney disease: a cross-sectional study
Authors
Jing Chang
Wenwen Hou
Yanchun Li
Shujuan Li
Kai Zhao
Yanfei Wang
Yuanping Hou
Qianmei Sun
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-022-03366-z

Other articles of this Issue 1/2022

BMC Geriatrics 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine